Cheng, X.; Han, X.; Si, J.; Dong, C.; Ji, Z.; Zhao, S.; Wu, X.; Li, H.; Jin, X.
Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation. Pharmaceutics 2024, 16, 1155.
https://doi.org/10.3390/pharmaceutics16091155
AMA Style
Cheng X, Han X, Si J, Dong C, Ji Z, Zhao S, Wu X, Li H, Jin X.
Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation. Pharmaceutics. 2024; 16(9):1155.
https://doi.org/10.3390/pharmaceutics16091155
Chicago/Turabian Style
Cheng, Xiang, Xiaoran Han, Jia Si, Cong Dong, Zhongjuan Ji, Shicong Zhao, Xiangting Wu, Haiyan Li, and Xiangqun Jin.
2024. "Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation" Pharmaceutics 16, no. 9: 1155.
https://doi.org/10.3390/pharmaceutics16091155
APA Style
Cheng, X., Han, X., Si, J., Dong, C., Ji, Z., Zhao, S., Wu, X., Li, H., & Jin, X.
(2024). Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation. Pharmaceutics, 16(9), 1155.
https://doi.org/10.3390/pharmaceutics16091155